QuickView for PPP2CB;jsessionid=10081F081AE3FEC9447F2D6AF3F672C1;jsessionid=12F259BBF1DC6FF0A7412AA5CE4A85CE;jsessionid=9B5FF14326083363AC8AB181178440D3 (gene)

Summary
General Info

Body Atlas

Most Correlated Tissues

Spinal cord
Frontal cortex
Amygdala
Corpus callosum
Hippocampus

Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

Injury of eye region
Poisoning by drug AND/OR medicinal substance
Toxic nephropathy
Anthrax
Hepatocellular dysplasia

Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

Cefotetan
Taurocholic Acid, Monosodium Salt
harpagoside
Ergocalciferols
Amanitins

Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

MAGEB6
PTHLH
PRELP
EDNRA
GSDME

Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Explore Curated Studies Results

Literature

Most Relevant Literature

The protein phosphatase Siw14 controls caffeine-induced nuclear localization and phosphorylation of …
PP2A-C may be a promising candidate for postmortem interval estimation.
c-Src inhibitor PP2 inhibits head and neck cancer progression through regulation of the epithelial-m…
PP2 protects from keratin mutation-associated liver injury and filament disruption via SRC kinase in…
PP2 alleviates the progression of osteoarthritis by inhibiting Wnt/β-catenin and activating TGF-β/Sm…

Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for PPP2CB;jsessionid=10081F081AE3FEC9447F2D6AF3F672C1;jsessionid=12F259BBF1DC6FF0A7412AA5CE4A85CE;jsessionid=9B5FF14326083363AC8AB181178440D3

Explore Clinical Trials Results